ARDS/Mechanical Ventilation

ARDS in the Time of COVID-19

Concurrent Session Moderator(s)

• 

  Robert Hyzy, MD, MCCM

  Professor of Internal Medicine, Director, CCMU
  University of Michigan Health System
  Ann Arbor, MI

  Disclosure(s): Merck: Advisory Board (Ongoing); Springer: Receipt of Royalties (Ongoing); UpToDate: Receipt of Royalties (Ongoing)

The experience of intensivists over the past three years of the global COVID-19 pandemic has been an outstanding opportunity to learn and reflect on the diagnosis and treatment of patients with the acute respiratory distress syndrome (ARDS). This session will explore ongoing issues in ARDS such as whether the Berlin criteria should be expanded, prevention of intubation, lung-protective ventilation, recruitment with positive end-expiratory pressure, and prone ventilation in the context of what we knew before the pandemic and what we have learned since its onset.

Presentations:

• Noninvasive Respiratory Support: In COVID-19 and Otherwise
  

  Concurrent Session Faculty: Robert Hyzy, MD, MCCM – University of Michigan Health System
• Adoption of Prone Ventilation in COVID-19: Will De-adoption Occur After the Pandemic?
  

  Concurrent Session Faculty: Javier Amador-Castaneda, BS, RRT – NewYork-Presbyterian Hospital
• Subphenotypes in ARDS: Is It Time for Personalized Medicine, Including for COVID-19 Patients?
  

  Concurrent Session Faculty: Carolyn S. Calfee, MD, MS – University of California San Francisco Medical Center
• Best PEEP in COVID-19 and Non-COVID-19 ARDS: Should Strategies Vary?
  

  Concurrent Session Faculty: Sarina Sahetya, MD – Johns Hopkins Hospital